Suppr超能文献

在无关的甲状腺激素抵抗患者中发现甲状腺激素受体β基因的三种新突变:同一密码子的两种突变(H435L和H435Q)产生不同亚型的抵抗。

Three novel mutations of thyroid hormone receptor beta gene in unrelated patients with resistance to thyroid hormone: two mutations of the same codon (H435L and H435Q) produce separate subtypes of resistance.

作者信息

Tsukaguchi H, Yoshimasa Y, Fujimoto K, Ishii H, Yamamoto T, Yoshimasa T, Yagura T, Takamatsu J

机构信息

Department of Endocrinology, Tenri Hospital, Nara, Japan.

出版信息

J Clin Endocrinol Metab. 1995 Dec;80(12):3613-6. doi: 10.1210/jcem.80.12.8530608.

Abstract

We report three novel mutations of the thyroid hormone receptor beta (TR beta) gene in three unrelated Japanese patients with resistance to thyroid hormone (RTH). Patients A and B exhibited generalized resistance phenotype, while patient C displayed more pituitary-selective unresponsiveness. Direct sequencing of TR beta gene exon 10 disclosed novel point mutations in all three patients. A Phe to Ile (TTC-->ATC) substitution at codon 451, a His to Leu (CAT-->CTT) substitution at codon 435, and a His to Gln (CAT-->CAA) substitution at codon 435 were identified in patients A, B, and C, respectively. Sequencing of TR beta gene exons 5-9 as well as TR alpha gene exons 4-9 failed to detect any additional mutations. All three patients were heterozygous for respective mutations. The unaffected parents of patients A and B, having normal thyroid function, possessed no mutations of TR beta gene exon 10, indicating that the F451I and H435L mutations occurred de novo. The F451I mutation is located near the most frequent mutation site in the ligand 2 subdomain. The identical codon mutations H435L and H435Q, which lie at the extreme carboxyl-terminus of the dimerization subdomain near the 9th heptad, were found in clinically different subtypes of RTH: patient B with generalized resistance and patient C with pituitary-selective resistance, respectively. The mutations broaden the growing catalogue of the TR beta gene mutations that could cause different phenotypes, despite the defects at the same codon.

摘要

我们报告了3名无亲缘关系的日本甲状腺激素抵抗(RTH)患者中甲状腺激素受体β(TRβ)基因的3种新突变。患者A和B表现出全身性抵抗表型,而患者C表现出更多垂体选择性无反应性。对TRβ基因外显子10进行直接测序发现,所有3名患者均有新的点突变。在患者A、B和C中分别鉴定出密码子451处苯丙氨酸到异亮氨酸(TTC→ATC)的替换、密码子435处组氨酸到亮氨酸(CAT→CTT)的替换以及密码子435处组氨酸到谷氨酰胺(CAT→CAA)的替换。对TRβ基因外显子5 - 9以及TRα基因外显子4 - 9进行测序未检测到任何其他突变。所有3名患者的各自突变均为杂合子。患者A和B未受影响的父母甲状腺功能正常,TRβ基因外显子10无突变,表明F451I和H435L突变是从头发生的。F451I突变位于配体2亚结构域中最常见突变位点附近。在临床不同亚型的RTH中发现了相同密码子的突变H435L和H435Q,它们位于二聚化亚结构域靠近第9个七肽的极端羧基末端,分别见于全身性抵抗的患者B和垂体选择性抵抗的患者C。这些突变拓宽了可能导致不同表型的TRβ基因突变的不断增加的目录,尽管是同一密码子处的缺陷。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验